antifungals
General Use
Treatment of fungal infections. Infections of skin or mucous membranes may be treated with topical or vaginal preparations. Deep-seated or systemic infections require oral or parenteral therapy. Lipid-based formulations of amphotericin employ lipid encapsulation technology designed to ↓ nephrotoxicity.
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Antifungals." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2024. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/50917/all/antifungals.
Vallerand AHA, Sanoski CAC, Quiring CC. Antifungals. Davis's Drug Guide. F.A. Davis Company; 2024. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/50917/all/antifungals. Accessed November 17, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2024). Antifungals. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/50917/all/antifungals
Vallerand AHA, Sanoski CAC, Quiring CC. Antifungals [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2024. [cited 2024 November 17]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/50917/all/antifungals.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - antifungals
ID - 50917
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/50917/all/antifungals
PB - F.A. Davis Company
ET - 19
DB - Medicine Central
DP - Unbound Medicine
ER -